GENSAVIS PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
GENSAVIS PHARMACEUTICALS, INC. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include NOVAMV, GENSAVIS, NOVAFERRUM, N NOVAFERRUM, and GENSAVIS PHARMACEUTICALS. The owner is based in GREENVILLE, SC.
204 WEST PARK AVENUE
GREENVILLE, SC 29601
Showing of trademarks Trademarks
Trademark Classifications
GENSAVIS PHARMACEUTICALS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does GENSAVIS PHARMACEUTICALS, INC. have?
GENSAVIS PHARMACEUTICALS, INC. has 12 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 abandoned, 2 cancelled.
What trademark classes does GENSAVIS PHARMACEUTICALS, INC. file in?
GENSAVIS PHARMACEUTICALS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GENSAVIS PHARMACEUTICALS, INC.'s most well-known trademarks?
GENSAVIS PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as NOVAMV, GENSAVIS, NOVAFERRUM, N NOVAFERRUM, and GENSAVIS PHARMACEUTICALS. These are among 7 currently registered trademarks in the portfolio.
What is GENSAVIS PHARMACEUTICALS, INC.'s trademark registration success rate?
GENSAVIS PHARMACEUTICALS, INC. has a 58% trademark registration rate, with 7 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.